Insider Transactions in Q4 2025 at Trans Medics Group, Inc. (TMDX)
Insider Transaction List (Q4 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 04
2025
|
Gerardo Hernandez Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
920
-5.76%
|
$127,880
$139.62 P/Share
|
|
Dec 03
2025
|
David Weill |
SELL
Open market or private sale
|
Direct |
5,000
-29.18%
|
$690,000
$138.64 P/Share
|
|
Dec 03
2025
|
David Weill |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+22.59%
|
$70,000
$14.2 P/Share
|
|
Nov 25
2025
|
Anil P. Ranganath |
SELL
Open market or private sale
|
Direct |
3,000
-17.69%
|
$435,000
$145.22 P/Share
|
|
Nov 25
2025
|
Anil P. Ranganath |
BUY
Exercise of conversion of derivative security
|
Direct |
3,000
+15.03%
|
$279,000
$93.88 P/Share
|
|
Nov 17
2025
|
Waleed H Hassanein President & CEO |
BUY
Open market or private purchase
|
Indirect |
8,775
+1.74%
|
$1,000,350
$114.0 P/Share
|
|
Oct 29
2025
|
Edward M Basile |
SELL
Open market or private sale
|
Direct |
4,142
-59.1%
|
$538,460
$130.45 P/Share
|
|
Oct 29
2025
|
Edward M Basile |
BUY
Exercise of conversion of derivative security
|
Direct |
4,142
+37.15%
|
$0
$0.7 P/Share
|